Establishment and Validation of a Novel Prediction Model for Early Natural Biochemical Recurrence After Radical Prostatectomy Based on Post-Operative PSA at Sixth Week

References

• Liesenfeld L, Kron M, Gschwend JE, Herkommer K. Prognostic factors for biochemical recurrence more than 10 years after radical prostatectomy. J Urol. 2017;197(1):143–148. doi:10.1016/j.juro.2016.07.004
   PubMed Web of Science ®Google Scholar
• Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;17(5):1499–1507. doi:10.1200/JCO.1999.17.5.1499
   PubMed Web of Science ®Google Scholar
• Thanigasalam R, Rasiah KK, Stricker PD, et al. Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram. BJU Int. 2010;105(5):642–647. doi:10.1111/j.1464-410X.2009.08842.x
   PubMed Web of Science ®Google Scholar
• Swanson GP, Yu C, Kattan MW, Hermans MR. Validation of postoperative nomograms in prostate cancer patients with long-term follow-up. Urology. 2011;78(1):105–109. doi:10.1016/j.urology.2011.01.061
   PubMed Web of Science ®Google Scholar
• Ondracek RP, Kattan MW, Murekeyisoni C, et al. Validation of the Kattan Nomogram for prostate cancer recurrence after radical prostatectomy. J Natl Comprehensive Cancer Ntwk. 2016;14(11):1395. doi:10.6004/jnccn.2016.0149
   PubMed Web of Science ®Google Scholar
• Moreira DM, Presti JC, Aronson WJ, et al. The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Prostate Cancer Prostatic Dis. 2010;13(1):87–93. doi:10.1038/pcan.2009.48
   PubMed Web of Science ®Google Scholar
• O’Brien BA, Cohen RJ, Wheeler TM, Moorin RE. A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis. BJU Int. 2011;107(3):389–395. doi:10.1111/j.1464-410X.2010.09539.x
   PubMed Web of Science ®Google Scholar
• Pompe RS, Bandini M, Preisser F, et al. Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram. Prostate Cancer Prostatic Dis. 2018;21(3):386–393. doi:10.1038/s41391-018-0033-1
   PubMed Web of Science ®Google Scholar
• Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169(2):517–523. doi:10.1016/S0022-5347(05)63946-8
   PubMed Web of Science ®Google Scholar
• Simmons MN, Stephenson AJ, Klein EA. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol. 2007;51(5):1175–1184. doi:10.1016/j.eururo.2007.01.015
   PubMed Web of Science ®Google Scholar
• Doherty AP, Bower M, Smith GL, et al. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer. 2000;83(11):1432–1436. doi:10.1054/bjoc.2000.1474
   PubMed Web of Science ®Google Scholar
• Vesely S, Jarolim L, Duskova K, Schmidt M, Dusek P, Babjuk M. The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy. BMC Urol. 2014;14:79. doi:10.1186/1471-2490-14-79
   PubMed Web of Science ®Google Scholar
• Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol. 2010;57(4):622–629. doi:10.1016/j.eururo.2009.03.077
   PubMed Web of Science ®Google Scholar
• Boccon-Gibod L, Djavan WB, Hammerer P, et al. Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. Int J Clin Pract. 2004;58(4):382–390. doi:10.1111/j.1368-5031.2004.00184.x
   PubMed Web of Science ®Google Scholar
• Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281(17):1591–1597. doi:10.1001/jama.281.17.1591
   PubMed Web of Science ®Google Scholar
• Campbell JM, Raymond E, O’Callaghan ME, et al. Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Clin Genitourin Cancer. 2017;15(5):e827–e834. doi:10.1016/j.clgc.2017.06.001
   PubMed Web of Science ®Google Scholar
• Marley J. Campbell‐Walsh Urology, 9th edition (E‐dition) ‐ Edited by AJ Wein, LR Kavoussi, AC Novick, AW Partin and CA Peters. Int J Urol Nurs. 2010;1(2):94–95. doi:10.1111/j.1749-771X.2007.00017.x
   Google Scholar
• Collins GS, Reitsma JB, Altman DG, Moons KG. Correction: transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(8):600. doi:10.7326/L15-0078-4
   Web of Science ®Google Scholar
• Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA. 2017;318(14):1377–1384. doi:10.1001/jama.2017.12126
   PubMed Web of Science ®Google Scholar
• Pencina MJ, Vasan RS, D’ Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine. 2008;27:157–172. doi:10.1002/sim.2929
   PubMed Web of Science ®Google Scholar
• Wessler BS, Lai YL, Kramer W, et al. Clinical prediction models for cardiovascular disease: the Tufts PACE CPM database. Circ Cardiovasc Qual Outcomes. 2015;8(4):368. doi:10.1161/CIRCOUTCOMES.115.001693
   PubMed Web of Science ®Google Scholar
• EAU Guidelines. Edn. Presented at the EAU Annual Congress. ISBN 978-94-92671-16-5. Amsterdam; 2022.
   Google Scholar